Female athletes are commonly diagnosed with functional hypothalamic amenorrhoea (FHA), where there is inhibition of the hypothalamic–pituitary–ovarian axis function and a reduction in gonadoliberin dipeptide (GnRH) secretion. This evidence concerns the gene GNRH1 and hypoalphalipoproteinemia, primary, 1.